|
1
|
Vidmar Golja M, Šmid A, Karas Kuželički N,
Trontelj J, Geršak K and Mlinarič-Raščan I: Folate insufficiency
due to MTHFR deficiency is bypassed by 5-methyltetrahydrofolate. J
Clin Med. 9(2836)2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Shannon B, Gnanasampanthan S, Beilby J and
Iacopetta B: A polymorphism in the methylenetetrahydrofolate
reductase gene predisposes to colorectal cancers with
microsatellite instability. Gut. 50:520–524. 2002.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Shiao S and Yu C: Meta-prediction of MTHFR
gene polymorphism mutations and associated risk for colorectal
cancer. Biol Res Nurs. 18:357–369. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Eaton AM, Sandler R, Carethers JM,
Millikan RC, Galanko J and Keku TO: 5,10-methylenetetrahydrofolate
reductase 677 and 1298 polymorphisms, folate intake, and
microsatellite instability in colon cancer. Cancer Epidemiol
Biomarkers Prev. 14:2023–2029. 2005.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Sohn KJ, Jang H, Campan M, Weisenberger
DJ, Dickhout J, Wang YC, Cho RC, Yates Z, Lucock M, Chiang EP, et
al: The methylenetetrahydrofolate reductase C677T mutation induces
cell-specific changes in genomic DNA methylation and uracil
misincorporation: A possible molecular basis for the site-specific
cancer risk modification. Int J Cancer. 124:1999–2005.
2009.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Abbasi IHR, Abbasi F, Wang L, Abd El Hack
ME, Swelum AA, Hao R, Yao J and Cao Y: Folate promotes S-adenosyl
methionine reactions and the microbial methylation cycle and boosts
ruminants production and reproduction. AMB Express.
8(65)2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Huang R and Zhou PK: DNA damage repair:
Historical perspectives, mechanistic pathways and clinical
translation for targeted cancer therapy. Signal Transduct Target
Ther. 6(254)2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Yousefzadeh M, Henpita C, Vyas R,
Soto-Palma C, Robbins P and Niedernhofer L: DNA damage-how and why
we age? eLife. 10(e62852)2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Hamza MS and Mousa SA: Cancer-associated
thrombosis: Risk factors, molecular mechanisms, future management.
Clin Appl Thromb Hemost. 26(1076029620954282)2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Garakanidze S, Costa E, Bronze-Rocha E,
Santos-Silva A, Nikolaishvili G, Nakashidze I, Kakauridze N, Glonti
S, Khukhunaishvili R, Koridze M and Ahmad S:
Methylenetetrahydrofolate reductase gene polymorphism (C677T) as a
risk factor for arterial thrombosis in Georgian patients. Clin Appl
Thromb Hemost. 24:1061–1066. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Moll S and Varga EA: Homocysteine and
MTHFR mutations. Circulation. 132:e6–e9. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kumar A, Palfrey HA, Pathak R, Kadowitz
PJ, Gettys TW and Murthy SN: The metabolism and significance of
homocysteine in nutrition and health. Nutr Metab (Lond).
14(78)2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Troesch B, Weber P and Mohajeri MH:
Potential links between impaired one-carbon metabolism due to
polymorphisms, inadequate B-vitamin status, and the development of
Alzheimer's disease. Nutrients. 8(803)2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Pushpakumar S, Kundu S and Sen U:
Endothelial dysfunction: The link between homocysteine and hydrogen
sulfide. Curr Med Chem. 21:3662–3672. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Donnellan E and Khorana AA: Cancer and
venous thromboembolic disease: A review. Oncologist. 22:199–207.
2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Erdinler IC, Ucer E, Eksik A, Akyol A and
Yazici S: Noncardiogenic pulmonary edema associated with
clopidogrel: A serious but unexpected side effect of clopidogrel.
Can J Cardiol. 23:478–480. 2007.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Antonaros F, Olivucci G, Cicchini E,
Ramacieri G, Pelleri MC, Vitale L, Strippoli P, Locatelli C, Cocchi
G, Piovesan A and Caracausi M: MTHFR C677T polymorphism analysis: A
simple, effective restriction enzyme-based method improving
previous protocols. Mol Genet Genomic Med. 7(e628)2019.PubMed/NCBI View
Article : Google Scholar
|
|
18
|
Raghubeer S and Matsha TE:
Methylenetetrahydrofolate (MTHFR), the one-carbon cycle, and
cardiovascular risks. Nutrients. 13(4562)2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Petrone I, Bernardo PS, Dos Santos EC and
Abdelhay E: MTHFR C677T and A1298C polymorphisms in breast cancer,
gliomas and gastric cancer: A review. Genes (Basel).
12(587)2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Rai V, Yadav U, Kumar P, Yadav SK and
Gupta S: Methylenetetrahydrofolate reductase A1298C genetic
variant& risk of schizophrenia: A meta-analysis. Indian J Med
Res. 145:437–447. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Graydon JS, Claudio K, Baker S, Kocherla
M, Ferreira M, Roche-Lima A, Rodríguez-Maldonado J, Duconge J and
Ruaño G: Ethnogeographic prevalence and implications of the
677C>T and 1298A>C MTHFR polymorphisms in US primary care
populations. Biomark Med. 13:649–661. 2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Nefic H, Mackic-Djurovic M and Eminovic I:
The frequency of the 677C>T and 1298A>C polymorphisms in the
methylenetetrahydrofolate reductase (MTHFR) gene in the population.
Med Arch. 72:164–169. 2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Brody LC, Conley M, Cox C, Kirke PN,
McKeever MP, Mills JL, Molloy AM, O'Leary VB, Parle-McDermott A,
Scott JM and Swanson DA: A polymorphism, R653Q, in the
trifunctional enzyme methylenetetrahydrofolate
dehydrogenase/methenyltetrahydrofolate
cyclohydrolase/formyltetrahydrofolate synthetase is a maternal
genetic risk factor for neural tube defects: Report of the Birth
Defects Research Group. Am J Hum Genet. 71:1207–1215.
2002.PubMed/NCBI View
Article : Google Scholar
|
|
24
|
Panteleimonitis S, Pickering O, Ahmad M,
Harper M, Qureshi T, Figueiredo N and Parvaiz A: Robotic rectal
cancer surgery: Results from a European multicentre case series of
240 resections and comparative analysis between cases performed
with the da Vinci Si and Xi systems. Laparosc Endosc Robot Surg.
3:6–11. 2020.
|
|
25
|
Hubner RA and Houlston RS: MTHFR C677T and
colorectal cancer risk: A meta-analysis of 25 populations. Int J
Cancer. 120:1027–1035. 2007.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhang P, Gao X, Zhang Y, Hu Y, Ma H, Wang
W, Wang H, Zhang J, Xu H and Lu Z: Association between MTHFR C677T
polymorphism and venous thromboembolism risk in the Chinese
population: a meta-analysis of 24 case-controlled studies.
Angiology. 66:422–432. 2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Jang MJ, Jeon YJ, Choi WI, Choi YS, Kim
SY, Chong SY, Oh D and Kim NK: The 677C>T mutation of the MTHFR
gene increases the risk of venous thromboembolism in Koreans and a
meta-analysis from Asian population. Clin Appl Thromb Hemost.
19:309–314. 2013.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Hoffbrand AV: Postgraduate Haematology.
7th edition. John Wiley & Sons, Ltd, Hoboken, NJ, 2016.
|
